ストックスクリーナーアプリを入手
2.54
1.60%
0.04
アフターアワーズ：
2.54
前日終値:
$2.50
開ける：
$2.51
24時間の取引高:
534.82K
Relative Volume:
0.63
時価総額：
$161.84M
収益：
$198.53M
当期純損益:
$-63.68M
株価収益率:
-2.4848
EPS:
-1.0222
ネットキャッシュフロー:
$-41.50M
1週間 パフォーマンス:
-2.31%
1か月 パフォーマンス:
+4.96%
6か月 パフォーマンス:
-55.44%
1年 パフォーマンス:
-73.81%
1日の値動き範囲:
$2.41
$2.55
1週間の範囲:
$2.41
$2.745
52週間の値動き範囲:
$2.36
$10.79
Treace Medical Concepts Inc Stock (TMCI) Company Profile
名前
Treace Medical Concepts Inc
セクター
電話
(904) 373-5940
住所
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
2.54 | 159.30M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-07 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-11-07 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-02-04 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-12-31 | 開始されました | Lake Street | Buy |
| 2024-12-17 | 再開されました | JP Morgan | Neutral |
| 2024-05-16 | ダウングレード | UBS | Buy → Neutral |
| 2024-05-08 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-05-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-05-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-08 | ダウングレード | Truist | Buy → Hold |
| 2023-09-29 | 開始されました | UBS | Buy |
| 2023-05-01 | 開始されました | Truist | Buy |
| 2023-04-11 | 開始されました | Stephens | Equal-Weight |
| 2022-05-12 | 開始されました | BTIG Research | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 開始されました | JP Morgan | Overweight |
| 2021-05-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 開始されました | SVB Leerink | Outperform |
| 2021-05-18 | 開始されました | Stifel | Buy |
すべてを表示
Treace Medical Concepts Inc (TMCI) 最新ニュース
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring A Potential 81% Upside - directorstalkinterviews.com
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
Treace Medical Concepts sees revenue fall in the fourth quarter - jaxdailyrecord.com
How New Analyst Targets Are Reframing The Treace Medical Concepts (TMCI) Investment Story - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Critical Analysis: Treace Medical Concepts (NASDAQ:TMCI) versus Adagio Medical (NASDAQ:ADGM) - Defense World
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Highlights 83.77% Potential Upside - directorstalkinterviews.com
Downgrade Watch: Will Treace Medical Concepts Inc stock hit new highs in YEARJuly 2025 Highlights & Detailed Earnings Play Alerts - baoquankhu1.vn
Treace Medical Concepts’ preliminary revenue down 9% in Q4 2025 - Medical Buyer
Treace Medical Issues Preliminary Q4 Results, Highlights Growth - TipRanks
Treace Medical Concepts, Inc. Provides Preliminary Revenue for the Fourth Quarter of 2025 - marketscreener.com
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - The Manila Times
Treace Medical Concepts Reports Preliminary 2025 Revenue Results and Updates on Surgeon Adoption Trends - Quiver Quantitative
Published on: 2026-01-13 05:27:40 - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
How Treace Medical Concepts Inc. stock compares to industry benchmarksAnalyst Downgrade & Advanced Technical Analysis Signals - ulpravda.ru
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - The Manila Times
Will Treace Medical Concepts Inc. stock recover faster than market2025 Valuation Update & Growth Oriented Trade Recommendations - Улправда
Will Treace Medical Concepts Inc. stock return to pre crisis levels2025 Pullback Review & AI Optimized Trading Strategy Guides - ulpravda.ru
Will Treace Medical Concepts Inc. stock outperform Nasdaq indexDollar Strength & High Accuracy Swing Entry Alerts - Улправда
Dow Theory LettersTreace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - FinancialContent
Is Treace Medical Concepts Inc. stock oversold or undervaluedMarket Activity Report & Accurate Intraday Trade Tips - Улправда
How Treace Medical Concepts Inc. stock reacts to Fed rate cutsJuly 2025 Spike Watch & Precise Buy Zone Identification - Улправда
How Treace Medical Concepts Inc. stock benefits from tech adoptionJuly 2025 Update & Breakout Confirmation Alerts - Улправда
The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts - Benzinga
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Low P/S - simplywall.st
How Recent Guidance Shifts Are Rewriting The Story For Treace Medical Concepts (TMCI) - Yahoo Finance
How Treace Medical Concepts Inc. stock performs during Fed tightening cycles2026 world cup usa national team round of 16 goalkeepers transition play odds analysis tactical review - Улправда
Treace Medical’s Earnings Call: Growth Amid Challenges - MSN
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical Concepts CEO John T. Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Bunion-focused medtech CEO to speak at J.P. Morgan Healthcare Conference - Stock Titan
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Trading Down 0.8%Time to Sell? - MarketBeat
Why hedge funds are buying Treace Medical Concepts Inc. stockWeekly Market Snapshot & Low Entry Cost Capital - bollywoodhelpline.com
Treace Medical’s Innovative Foot Correction Study: A Potential Game-Changer? - MSN
Can Treace Medical Concepts Stock Recover If Markets Fall? - Trefis
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)June 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
What valuation multiples suggest for Treace Medical Concepts Inc. stock2025 Retail Activity & Capital Efficiency Focused Ideas - Улправда
Treace Medical raises USD 175M in debt financing - Medical Buyer
Is Treace Medical Concepts Inc. stock a contrarian buy2025 Winners & Losers & Free High Return Stock Watch Alerts - Улправда
Treace Medical Completes New Secured Loan Financing Deal - The Globe and Mail
Is Treace Medical Concepts Inc. stock resilient to inflationWeekly Loss Report & Safe Entry Momentum Stock Tips - DonanımHaber
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - ACCESS Newswire
Treace Medical Concepts (TMCI) Analyst Rating Update: Truist Sec - GuruFocus
Treace Medical Concepts, Inc. Secures Up to $175 Million in Debt Financing - marketscreener.com
Treace Medical Concepts Inc (TMCI) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
0.96%
大文字化:
|
ボリューム (24 時間):